Literature DB >> 17395336

The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.

Qi Li1, Gang Lu, G E Antonio, Y T Mak, John A Rudd, Ming Fan, David T Yew.   

Abstract

Spontaneously hypertensive rats (SHR) are considered to represent a genetic animal model for attention-deficit hyperactivity disorder (ADHD). In the present studies, we compared the locomotor activity, learning and memory functions of juvenile male SHR, with age- and gender-matched genetic control Wistar-Kyoto rats (WKY). In addition, we investigated potential differences in brain morphology by magnetic resonance imaging (MRI). In other complimentary studies of the central nervous system, we used real-time PCR to examine the levels of several dopaminergic-related genes, including those coding for the five major subtypes of dopamine receptor (D1, D2, D3, D4 and D5), those coding for enzymes responsible for synthesizing tyrosine hydroxylase and dopamine-beta-hydroxylase, and those coding for the dopamine transporter. Our data revealed that SHR were more active than WKY in the open field (OF) test. Also, SHR appeared less attentive, exhibiting inhibition deficit, but in the absence of memory deficits relative to spatial learning. The MRI studies revealed that SHR had a significantly smaller vermis cerebelli and caudate-putamen (CPu), and there was also a significantly lower level of dopamine D4 receptor gene expression and protein synthesis in the prefrontal cortex (PFC) of SHR. However, there were no significant differences between the expression of other dopaminergic-related genes in the midbrain, prefrontal cortex, temporal cortex, striatum, or amygdala of SHR and WKY. The data are similar to the situation seen in ADHD patients, relative to normal volunteers, and it is possible that the hypo-dopaminergic state involves a down regulation of dopamine D4 receptors, rather than a general down-regulation of catecholamine synthesis. In conclusion, the molecular and behavioural data that we obtained provide new information that may be relevant to understanding ADHD in man.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395336     DOI: 10.1016/j.neuint.2007.02.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  27 in total

1.  Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.

Authors:  Michael Michaelides; Javier Pascau; Juan-Domingo Gispert; Foteini Delis; David K Grandy; Gene-Jack Wang; Manuel Desco; Marcelo Rubinstein; Nora D Volkow; Panayotis K Thanos
Journal:  Eur J Neurosci       Date:  2010-07-16       Impact factor: 3.386

2.  Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals.

Authors:  L Y Yeung; H F Kung; David T Yew
Journal:  Age (Dordr)       Date:  2010-05-28

3.  Conditioned inhibition in a rodent model of attention-deficit/hyperactivity disorder.

Authors:  John T Green; Amy C Chess; Cynthia J Conquest; Brittney A Yegla
Journal:  Behav Neurosci       Date:  2011-10-17       Impact factor: 1.912

4.  Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.

Authors:  Yukio Ago; Masato Umehara; Kosuke Higashino; Shigeru Hasebe; Kazumi Fujita; Kazuhiro Takuma; Toshio Matsuda
Journal:  Neurochem Res       Date:  2014-03-15       Impact factor: 3.996

Review 5.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

6.  Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.

Authors:  Chloe J Jordan; Danielle M Taylor; Linda P Dwoskin; Kathleen M Kantak
Journal:  Behav Brain Res       Date:  2015-10-20       Impact factor: 3.332

7.  Methylphenidate treatment leads to abnormalities on krebs cycle enzymes in the brain of young and adult rats.

Authors:  Gislaine Z Réus; Giselli Scaini; Camila B Furlanetto; Meline O S Morais; Isabela C Jeremias; Lis Mairá Mello-Santos; Karolina V Freitas; João Quevedo; Emilio L Streck
Journal:  Neurotox Res       Date:  2013-02-20       Impact factor: 3.911

8.  Medial temporal lobe functioning and structure in the spontaneously hypertensive rat: comparison with Wistar-Kyoto normotensive and Wistar-Kyoto hypertensive strains.

Authors:  Audrey M Wells; Amy C Janes; Xiaoxu Liu; Christian F Deschepper; Marc J Kaufman; Kathleen M Kantak
Journal:  Hippocampus       Date:  2010-06       Impact factor: 3.899

Review 9.  The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain.

Authors:  Terje Sagvolden; Espen Borgå Johansen; Grete Wøien; S Ivar Walaas; Jon Storm-Mathisen; Linda Hildegard Bergersen; Oivind Hvalby; Vidar Jensen; Heidi Aase; Vivienne A Russell; Peter R Killeen; Tania Dasbanerjee; Frank A Middleton; Stephen V Faraone
Journal:  Neuropharmacology       Date:  2009-08-19       Impact factor: 5.250

10.  The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Vivienne A Russell; Greg A Gerhardt; Paul E A Glaser
Journal:  Neuropharmacology       Date:  2012-09-01       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.